#sbnsdundee #iih Thanks to @The_SBNS for inviting us to present the findings of the IIHWT trial demonstrating improved outcome for patients after bariatric surgery @DrMollan @IIHDrBirmingham @DrAndreasY
@IIHDrBirmingham presenting a sneak peek at IIH Pressure Trial data at Headstart meeting @tevapharmeurope exciting potential new treatment for raised ICP! @DrMollan @DrAndreasY @IIHUK
Thanks @DrAndreasY for a really interesting talk on the use of CGRP therapies in IIH, exciting data @IIHDrBirmingham @IIHUK @DrMollan
@DrMollan speaking about Giant Cell Arteritis at tonight’s Headstart meeting @tevapharmeurope @IIHDrBirmingham @petergoadsby
@DrMollan presenting the @EHF_Official IiH guidelines and new research in IIH from @IIHDrBirmingham @BHPComms at the #HeadacheAcademy @RCPLondon promising future with improved care for IIH @IIHUK @Manjit_Matharu
@ConnarWestgate Dr Westgate presenting aspects of his PhD, describing the metabolic phenotype of #IIH adipose tissue @IIHUK @IIHDrBirmingham
Prof Sinclair @IIHDrBirmingham presenting evidence to the Danish Headache Conference, IIH is a metabolic disease and this is opening new avenues for treatment in the future! @IIHUK @DrMollan @DrAndreasY
Prof Alex Sinclair @IIHDrBirmingham at Danish Headache Conference #Copenhagen discussing the unique hormone profile of IIH, exciting work unpicking the underlying cause of IIH @IIHUK @DrAndreasY @DrMollan
Long term effectiveness of Erenumab, ongoing reductions at 5 years of treatment, very well tolerated @MessoudAshina










